4.4 Article

From Catastrophizing to Recovery: a pilot study of a single-session treatment for pain catastrophizing

期刊

JOURNAL OF PAIN RESEARCH
卷 7, 期 -, 页码 219-226

出版社

DOVE MEDICAL PRESS LTD
DOI: 10.2147/JPR.S62329

关键词

chronic pain; cognitive behavioral therapy; pain treatment; chronic debilitation; pain treatment costs; pain psychology

资金

  1. National Institutes of Health (NIH): National Center for Complementary and Alternative Medicine (NCCAM) [P01AT006651, P01AT006651S1, K24DA029262, HHSN271201200728P]
  2. National Center for Research Resources (NCRR) (Stanford University) [UL1 RR025744]
  3. Chris Redlich Pain Research Endowment

向作者/读者索取更多资源

Background: Pain catastrophizing (PC) - a pattern of negative cognitive-emotional responses to real or anticipated pain - maintains chronic pain and undermines medical treatments. Standard PC treatment involves multiple sessions of cognitive behavioral therapy. To provide efficient treatment, we developed a single-session, 2-hour class that solely treats PC entitled From Catastrophizing to Recovery [FCR]. Objectives: To determine 1) feasibility of FCR; 2) participant ratings for acceptability, understandability, satisfaction, and likelihood to use the information learned; and 3) preliminary efficacy of FCR for reducing PC. Design and methods: Uncontrolled prospective pilot trial with a retrospective chart and database review component. Seventy-six patients receiving care at an outpatient pain clinic (the Stanford Pain Management Center) attended the class as free treatment and 70 attendees completed and returned an anonymous survey immediately post-class. The Pain Catastrophizing Scale (PCS) was administered at class check-in (baseline) and at 2, and 4 weeks post-treatment. Within subjects repeated measures analysis of variance (ANOVA) with Student's t-test contrasts were used to compare scores across time points. Results: All attendees who completed a baseline PCS were included as study participants (N=57; F=82%; mean age =50.2 years); PCS was completed by 46 participants at week 2 and 35 participants at week 4. Participants had significantly reduced PC at both time points (P<0001) and large effect sizes were found (Cohen's d=0.85 and d=1.15). Conclusion: Preliminary data suggest that FCR is an acceptable and effective treatment for PC. Larger, controlled studies of longer duration are needed to determine durability of response, factors contributing to response, and the impact on pain, function and quality of life.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据